Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression to Type 2 diabetes in prediabetic patients, the Indianapolis-based ...

Nov 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of weekly injections. The results ...

Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...

A recent study indicates that adults with mild type 2 diabetes might enhance their beta-cell function by adopting a low-carbohydrate diet. Experts are concerned about the low-carb diet’s ...

Adults with type 2 diabetes on a low-carbohydrate diet may see benefits to their beta-cell function, allowing them to better manage their disease and possibly discontinue medication, according to ...

People with Type 2 diabetes have a compromised beta-cell response to blood sugar, possibly due in part to eating too many carbohydrates. Beta-cell failure or insufficiency on top of insulin resistance ...

NEW YORK, Oct. 22 (UPI) --A low-carbohydrate diet may help adults with type 2 diabetes gain better blood sugar control and make it possible to decrease diabetes medication, a new study suggests.